Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
Authors
Keywords
-
Journal
ONCOGENE
Volume 32, Issue 1, Pages 86-96
Publisher
Springer Nature
Online
2012-02-06
DOI
10.1038/onc.2012.25
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
- (2017) R. Dummer et al. JOURNAL OF CLINICAL ONCOLOGY
- A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer
- (2011) M. N. Fornier et al. ANNALS OF ONCOLOGY
- Oncogenic BRAF Induces Melanoma Cell Invasion by Downregulating the cGMP-Specific Phosphodiesterase PDE5A
- (2011) Imanol Arozarena et al. CANCER CELL
- Phase II Trial of Dasatinib for Patients with Acquired Resistance to Treatment with the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Erlotinib or Gefitinib
- (2011) Melissa L. Johnson et al. Journal of Thoracic Oncology
- Biological challenges of BRAF inhibitor therapy
- (2011) Igor Puzanov et al. Molecular Oncology
- In melanoma, beta-catenin is a suppressor of invasion
- (2011) I Arozarena et al. ONCOGENE
- BRAF as therapeutic target in melanoma
- (2010) Claudia Wellbrock et al. BIOCHEMICAL PHARMACOLOGY
- A phase 2 trial of dasatinib in advanced melanoma
- (2010) Harriet M. Kluger et al. CANCER
- Activation of FOXO3a Is Sufficient to Reverse Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase Inhibitor Chemoresistance in Human Cancer
- (2010) Jer-Yen Yang et al. CANCER RESEARCH
- Basal and Treatment-Induced Activation of AKT Mediates Resistance to Cell Death by AZD6244 (ARRY-142886) in Braf-Mutant Human Cutaneous Melanoma Cells
- (2010) Y. N. V. Gopal et al. CANCER RESEARCH
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
- (2010) Sonja J. Heidorn et al. CELL
- Elevated c-Src and c-Yes expression in malignant skin cancers
- (2010) Jang Lee et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Extracellular Signal-Regulated Kinase Promotes Rho-Dependent Focal Adhesion Formation by Suppressing p190A RhoGAP
- (2010) A. K. Pullikuth et al. MOLECULAR AND CELLULAR BIOLOGY
- MMP13 mediates cell cycle progression in melanocytes and melanoma cells: in vitro studies of migration and proliferation
- (2010) Svenja Meierjohann et al. Molecular Cancer
- Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma
- (2010) Gideon Bollag et al. NATURE
- Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways
- (2010) S-H Lee et al. ONCOGENE
- Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion
- (2009) Shuh Narumiya et al. CANCER AND METASTASIS REVIEWS
- Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited
- (2009) Farideh Sabeh et al. JOURNAL OF CELL BIOLOGY
- Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma
- (2009) Jade Homsi et al. MELANOMA RESEARCH
- FAK Phosphorylation by ERK Primes Ras-Induced Tyrosine Dephosphorylation of FAK Mediated by PIN1 and PTP-PEST
- (2009) Yanhua Zheng et al. MOLECULAR CELL
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Rac Activation and Inactivation Control Plasticity of Tumor Cell Movement
- (2008) Victoria Sanz-Moreno et al. CELL
- Src and focal adhesion kinase as therapeutic targets in cancer
- (2008) Valerie G Brunton et al. CURRENT OPINION IN PHARMACOLOGY
- p190RhoGAP is the convergence point of adhesion signals from α5β1integrin and syndecan-4
- (2008) Mark D. Bass et al. JOURNAL OF CELL BIOLOGY
- Cell motility through plasma membrane blebbing
- (2008) Oliver T. Fackler et al. JOURNAL OF CELL BIOLOGY
- Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines
- (2008) Alex J Eustace et al. Journal of Translational Medicine
- Inhibition of Src Family Kinases with Dasatinib Blocks Migration and Invasion of Human Melanoma Cells
- (2008) R. Buettner et al. MOLECULAR CANCER RESEARCH
- mda-9/Syntenin promotes metastasis in human melanoma cells by activating c-Src
- (2008) H. Boukerche et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now